$AIP

Arteris, Inc. (AIP) Reports Q2 Loss, Tops Revenue Estimates

Arteris, Inc. (AIP) reported Q2 adjusted EPS loss of $0.10 per share, compared with a Zacks Consensus loss of $0.05 and a year-ago loss of $0.11. Revenue rose to $24.13 million, above the $23.47 million estimate. The article cites a Zacks Rank #3 (Hold) and notes upcoming consensus EPS of -$0.02 for the next quarter.

Original reporting
Published Aug 6, 2026, 11:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 4:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
7/10
alphai data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$AIPNeutralMed
01

Why it matters

Traders can use the reported EPS and revenue surprises plus the stated consensus outlook for the coming quarter and fiscal year to gauge whether the earnings call is likely to revise expectations upward or downward.

02

Market read

A concrete earnings print with quantified EPS and revenue surprises, but the article’s forward signal is limited to current consensus and the expectation that management commentary will drive the next move.

03

What to watch

The article highlights the Zacks Rank as Hold but does not detail backlog, margins, or cash flow, which could dominate the market reaction if they diverge from consensus.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session positioning following the Q2 earnings release

Background

The piece summarizes Arteris’ Q2 adjusted results versus Zacks Consensus and discusses how estimate revisions and the earnings outlook may drive the stock.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris reported Q2 adjusted EPS of -$0.10 versus -$0.05 consensus and revenue of $24.13M, beating estimates by 2.86%.

Expected impact

Likely choppy trading around the earnings call, with bias toward whichever guidance/trajectory management emphasizes.

Evidence & confidence

The article provides the surprise metrics and notes the stock’s near-term move will depend on management commentary, but it does not include specific guidance changes beyond current consensus outlook.

Market effects

Signals ongoing volatility in small-cap semiconductor/industrial tech earnings quality, where revenue beats may not offset EPS pressure.

No explicit regional spillover beyond US small-cap sentiment.

Limited, as the article contains no international demand, regulatory, or supply-chain developments.

Counterpoint

The EPS miss may be less important if management frames profitability improvement or cost normalization, especially given the consistent revenue estimate beats.

Key entities

  • Arteris, Inc.

    Reported Q2 adjusted EPS of -$0.10 and revenue of $24.13M, with EPS missing consensus and revenue beating.

  • Zacks Consensus Estimate

    The benchmark used to quantify the EPS and revenue surprises in the article.

Related articles

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.